Health and Human Services Logo

  U.S. Department of Health and Human Services | National Institutes of Health

Versions Compared

Old Version 1

changes.mady.by.user Swan, Jeremy (NIH/NICHD) [C]

Saved on

compared with

New Version 2

changes.mady.by.user Swan, Jeremy (NIH/NICHD) [C]

Saved on

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

...

Div
classusa-grid
Div
classusa-width-two-thirds

In two patients we had seen tumors shrink, and in one case disappear, after our immunotherapy. After all the deaths, after all the years in the lab, we had found something that worked. For the first time I believed — rather than hoped — immunotherapy not only could work, but would work.

  • –Steven A. Rosenberg, M.D.
    The Transformed Cell

During the era of President Richard M. Nixon, political turmoil engendered by the Vietnam conflict reverberated throughout the biomedical research world built by federal funding and NIH sponsorship in the previous decade. The Clinical Center had its antiwar demonstrations and counter-demonstrations, and civil rights issues led to a vigorous affirmative action program to widen the opportunities for minorities.

Footnote

Minutes, Clinical Center staff meetings: May 6, 1969; July 15, 1969; November 18, 1969; April 20, 1971; box 3, RG 443.

The war also brought demographic change within the hospital community. The end of the “doctor draft” in 1972 resulted in a steep falloff in Clinical Associate applications and jeopardized a critical source of new staff physicians. Normal volunteers were less often Mennonites and other conscientious objectors and increasingly were drawn from a national network of small colleges.

Footnote

Minutes, Clinical Directors special meeting, February 25, 1974; minutes, Medical Board meeting, October 27, 1970.

Div
classusa-width-one-third

Dr. Andrew Morrow in SurgeryImage Removed
Dr. Andrew Morrow in surgery, inserting dye into patient's heart with a bronchoscope, a technique developed at the Clinical Center.

First Patient in the ADA Gene Therapy ProgramImage Removed
Dr. W. French Anderson (l.), Dr. Michael Blaese (r.), and Dr. Kenneth Culver (c.) attending the first patient in the ADA gene therapy program, September 1990. The patient is undergoing apheresis.

The greatest challenge the Clinical Center faced came directly from the Nixon administration. In the name of budgetary restraint and managerial efficiency, the administration sought to curtail research spending, reduce federal support for biomedical education, and to phase out the PHS hospital system. Congress, however, wanted to redirect spending away from the war effort. A collision course was set in 1971 and 1972 when broad majorities in both houses voted massive new outlays to conquer cancer, heart, and lung disease. The administration supported these initiatives but insisted that off-setting cuts be made in other health areas. As a result, the budgets of NIH categorical institutes other than Cancer and Heart, Lung, and Blood registered absolute declines in 1973. 


The greatest challenge the Clinical Center faced came directly from the Nixon administration. In the name of budgetary restraint and managerial efficiency, the administration sought to curtail research spending, reduce federal support for biomedical education, and to phase out the PHS hospital system. Congress, however, wanted to redirect spending away from the war effort. A collision course was set in 1971 and 1972 when broad majorities in both houses voted massive new outlays to conquer cancer, heart, and lung disease. The administration supported these initiatives but insisted that off-setting cuts be made in other health areas. As a result, the budgets of NIH categorical institutes other than Cancer and Heart, Lung, and Blood registered absolute declines in 1973. 

Footnote

Richard A. Rettig, Cancer Crusade: The Story of the National Cancer Act of 1971, Princeton: Princeton University Press, 1977, pp. 30-35; Science, 183: 1325-26, December 28, 1973.

Div
classusa-width-one-third

Dr. Andrew Morrow in SurgeryImage Added
Dr. Andrew Morrow in surgery, inserting dye into patient's heart with a bronchoscope, a technique developed at the Clinical Center.

First Patient in the ADA Gene Therapy ProgramImage Added
Dr. W. French Anderson (l.), Dr. Michael Blaese (r.), and Dr. Kenneth Culver (c.) attending the first patient in the ADA gene therapy program, September 1990. The patient is undergoing apheresis

Footnote
Richard A. Rettig, Cancer Crusade: The Story of the National Cancer Act of 1971, Princeton: Princeton University Press, 1977, pp. 30-35; Science, 183: 1325-26, December 28, 1973

.

A personnel ceiling remained in place for NIH as a whole, so that while NIH funding rose $946 million between 1968 and 1975, permanent staff lost 350 positions, and much of this burden fell on the Clinical Center.

Footnote

NIH Program Review, 1975, box 8, folder, “Clinical Center Reorganization, 1974-1975,” RG443.

...
Return to top